DANNY EAPEN to Risk Assessment
This is a "connection" page, showing publications DANNY EAPEN has written about Risk Assessment.
Connection Strength
0.188
-
Novel biomarkers for cardiovascular risk assessment: current status and future directions. Future Cardiol. 2015 Sep; 11(5):597-613.
Score: 0.059
-
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc. 2014 10 23; 3(5):e001118.
Score: 0.056
-
Navigating air travel and cardiovascular concerns: Is the sky the limit? Clin Cardiol. 2017 Sep; 40(9):660-666.
Score: 0.017
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death. Circ Cardiovasc Qual Outcomes. 2017 03; 10(3).
Score: 0.016
-
Physical activity in the prevention of coronary heart disease: implications for the clinician. Heart. 2016 06 15; 102(12):904-9.
Score: 0.015
-
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol. 2014 Apr; 21(2):233-44.
Score: 0.013
-
The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr Atheroscler Rep. 2011 Apr; 13(2):154-61.
Score: 0.011